BGT Stock Overview
An agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Bio-Gene Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.043 |
| 52 Week High | AU$0.082 |
| 52 Week Low | AU$0.038 |
| Beta | 0.71 |
| 11 Month Change | -20.37% |
| 3 Month Change | -8.51% |
| 1 Year Change | -28.33% |
| 33 Year Change | -77.95% |
| 5 Year Change | -69.29% |
| Change since IPO | -81.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| BGT | AU Chemicals | AU Market | |
|---|---|---|---|
| 7D | 4.9% | 0.7% | 1.5% |
| 1Y | -28.3% | 5.6% | 17.9% |
Return vs Industry: BGT underperformed the Australian Chemicals industry which returned 6.5% over the past year.
Return vs Market: BGT underperformed the Australian Market which returned 18.1% over the past year.
Price Volatility
| BGT volatility | |
|---|---|
| BGT Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 10.7% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: BGT's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine BGT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Tim Grogan | www.bio-gene.com.au |
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University to support research and field operations relating to processing and distillation of oil from biomass; AgriFor Scientific, a chemistry product; cesar for assessing the insecticidal activity of molecules against a various insect species; CSIRO, a chemistry development process; Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University, a chemical analysis of natural products; University of Florida; and University of Technology.
Bio-Gene Technology Limited Fundamentals Summary
| BGT fundamental statistics | |
|---|---|
| Market cap | AU$8.66m |
| Earnings (TTM) | -AU$2.41m |
| Revenue (TTM) | AU$18.32k |
472.6x
P/S Ratio-3.6x
P/E RatioIs BGT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGT income statement (TTM) | |
|---|---|
| Revenue | AU$18.32k |
| Cost of Revenue | AU$319.77k |
| Gross Profit | -AU$301.45k |
| Other Expenses | AU$2.11m |
| Earnings | -AU$2.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | -1,645.46% |
| Net Profit Margin | -13,150.54% |
| Debt/Equity Ratio | 0% |
How did BGT perform over the long term?
See historical performance and comparison